BIRD B. AG
Overview
BIRD B. AG is a Swiss-based, globally active investment company founded in 2003. The firm invests in early-stage to late-stage growth companies in the medical field, with a focus on innovative orthopedic implants, surgery technologies, supportive systems, software, AI, and robotics. It operates with an evergreen strategy, taking long-term perspectives on its investments. The company's portfolio includes businesses in medical device manufacturing, biomaterials, orthopedics, and cardiovascular treatments.
Portfolio Companies
3
Website
bird-b.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Starlight Cardiovascular | Oct 2022 | Series A | Lead |
| Proprio | Jul 2023 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BIRD B. AG based?
BIRD B. AG is headquartered in Schaffhausen, Schaffhausen, Switzerland.
When was BIRD B. AG founded?
Founding year information for BIRD B. AG is not publicly available.
How many portfolio companies does BIRD B. AG have?
BIRD B. AG has 3 portfolio companies in Caplight's dataset.
What are some companies in BIRD B. AG's portfolio?
Portfolio companies visible on Caplight include Starlight Cardiovascular, Proprio.
What was BIRD B. AG's most recent investment shown here?
BIRD B. AG's most recent investment in this portfolio sample was in Proprio in 2023.
What sectors does BIRD B. AG focus on?
BIRD B. AG focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does BIRD B. AG focus on?
BIRD B. AG typically invests at the Mid stage.